Fairmount Funds Management LLC bought ZBIO
March 31, 2026 · Form 4 insider transaction
Fairmount Funds Management LLC bought 150,000 shares of Zenas BioPharma, Inc. at $20.00 per share, a transaction worth $3.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
$20.00
Total value
$3.00M
Role—
CompanyZenas BioPharma, Inc. (ZBIO)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 31, 2026
Filing dateApril 1, 2026
Shares owned after2,359,025
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.